| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 39 | 2026 | 863 | 4.220 |
Why?
|
| Myocardial Infarction | 40 | 2018 | 919 | 2.870 |
Why?
|
| Acute Coronary Syndrome | 23 | 2021 | 253 | 2.780 |
Why?
|
| Residence Characteristics | 18 | 2026 | 230 | 2.200 |
Why?
|
| Socioeconomic Factors | 46 | 2026 | 801 | 2.020 |
Why?
|
| Risk Factors | 106 | 2026 | 5429 | 2.000 |
Why?
|
| Coronary Artery Disease | 25 | 2026 | 324 | 2.000 |
Why?
|
| Hypertension | 25 | 2026 | 612 | 1.890 |
Why?
|
| Male | 233 | 2026 | 31047 | 1.860 |
Why?
|
| Female | 243 | 2026 | 34018 | 1.840 |
Why?
|
| United States | 135 | 2026 | 8093 | 1.820 |
Why?
|
| Humans | 317 | 2026 | 65140 | 1.700 |
Why?
|
| Health Behavior | 12 | 2026 | 484 | 1.680 |
Why?
|
| Body Mass Index | 23 | 2026 | 897 | 1.650 |
Why?
|
| Quality of Health Care | 13 | 2019 | 528 | 1.620 |
Why?
|
| Young Adult | 63 | 2026 | 4809 | 1.570 |
Why?
|
| Adult | 144 | 2026 | 17358 | 1.500 |
Why?
|
| Medicare | 24 | 2020 | 625 | 1.490 |
Why?
|
| Life Style | 6 | 2026 | 321 | 1.430 |
Why?
|
| Middle Aged | 132 | 2026 | 18273 | 1.420 |
Why?
|
| Prejudice | 7 | 2020 | 61 | 1.390 |
Why?
|
| Smoking | 24 | 2021 | 862 | 1.350 |
Why?
|
| Internet | 11 | 2018 | 467 | 1.230 |
Why?
|
| Coronary Vessels | 10 | 2024 | 125 | 1.230 |
Why?
|
| Hospitalization | 21 | 2026 | 1392 | 1.230 |
Why?
|
| Aged | 111 | 2025 | 14965 | 1.200 |
Why?
|
| Longitudinal Studies | 52 | 2025 | 1282 | 1.200 |
Why?
|
| Practice Patterns, Physicians' | 14 | 2019 | 706 | 1.200 |
Why?
|
| General Surgery | 6 | 2019 | 210 | 1.150 |
Why?
|
| Quality Indicators, Health Care | 13 | 2021 | 346 | 1.120 |
Why?
|
| Alcohol Drinking | 9 | 2018 | 322 | 1.110 |
Why?
|
| Obesity | 20 | 2026 | 1274 | 1.090 |
Why?
|
| Coronary Disease | 17 | 2011 | 246 | 1.090 |
Why?
|
| Healthcare Disparities | 11 | 2020 | 407 | 1.040 |
Why?
|
| Quality of Life | 18 | 2023 | 1260 | 1.020 |
Why?
|
| Health Services Accessibility | 18 | 2018 | 591 | 1.010 |
Why?
|
| Health Status | 16 | 2024 | 447 | 1.000 |
Why?
|
| Emergency Medical Services | 5 | 2020 | 261 | 1.000 |
Why?
|
| Adolescent | 65 | 2026 | 6297 | 0.970 |
Why?
|
| Depression | 16 | 2024 | 900 | 0.970 |
Why?
|
| Blood Pressure | 17 | 2026 | 526 | 0.970 |
Why?
|
| Exercise | 13 | 2026 | 964 | 0.960 |
Why?
|
| Cohort Studies | 40 | 2024 | 2620 | 0.950 |
Why?
|
| Cognition Disorders | 3 | 2017 | 223 | 0.950 |
Why?
|
| Surgery Department, Hospital | 4 | 2015 | 19 | 0.940 |
Why?
|
| Health Status Disparities | 7 | 2023 | 147 | 0.930 |
Why?
|
| Health Services Research | 19 | 2017 | 265 | 0.930 |
Why?
|
| Patient Discharge | 14 | 2021 | 519 | 0.920 |
Why?
|
| Frailty | 6 | 2023 | 130 | 0.900 |
Why?
|
| Poverty | 11 | 2014 | 304 | 0.900 |
Why?
|
| Benchmarking | 10 | 2008 | 137 | 0.890 |
Why?
|
| Sex Factors | 26 | 2024 | 992 | 0.880 |
Why?
|
| Social Determinants of Health | 7 | 2026 | 150 | 0.880 |
Why?
|
| Cognition | 5 | 2022 | 508 | 0.870 |
Why?
|
| Patient Readmission | 9 | 2021 | 451 | 0.840 |
Why?
|
| Religion | 3 | 2019 | 35 | 0.830 |
Why?
|
| Atrial Fibrillation | 9 | 2023 | 879 | 0.810 |
Why?
|
| Guideline Adherence | 8 | 2019 | 307 | 0.800 |
Why?
|
| Risk Assessment | 28 | 2026 | 2102 | 0.800 |
Why?
|
| Smoking Cessation | 13 | 2016 | 553 | 0.780 |
Why?
|
| Prospective Studies | 46 | 2023 | 3308 | 0.780 |
Why?
|
| Social Class | 12 | 2026 | 137 | 0.750 |
Why?
|
| Multivariate Analysis | 24 | 2017 | 930 | 0.730 |
Why?
|
| Income | 12 | 2020 | 169 | 0.720 |
Why?
|
| Hospitals | 9 | 2019 | 387 | 0.710 |
Why?
|
| Total Quality Management | 9 | 2004 | 56 | 0.700 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 250 | 0.700 |
Why?
|
| Odds Ratio | 21 | 2021 | 754 | 0.700 |
Why?
|
| Logistic Models | 28 | 2021 | 1269 | 0.690 |
Why?
|
| Angina, Unstable | 4 | 2006 | 56 | 0.670 |
Why?
|
| Stroke | 10 | 2022 | 1211 | 0.660 |
Why?
|
| Age Factors | 24 | 2024 | 1586 | 0.650 |
Why?
|
| Interpersonal Relations | 2 | 2020 | 160 | 0.640 |
Why?
|
| Surveys and Questionnaires | 27 | 2023 | 2757 | 0.640 |
Why?
|
| Patient Selection | 7 | 2011 | 485 | 0.640 |
Why?
|
| Aged, 80 and over | 42 | 2020 | 5614 | 0.630 |
Why?
|
| Alabama | 26 | 2011 | 85 | 0.620 |
Why?
|
| Cross-Sectional Studies | 36 | 2023 | 2701 | 0.620 |
Why?
|
| Hospital Mortality | 20 | 2019 | 875 | 0.620 |
Why?
|
| Massachusetts | 20 | 2023 | 2145 | 0.620 |
Why?
|
| Insurance, Health | 7 | 2016 | 151 | 0.610 |
Why?
|
| Time Factors | 30 | 2020 | 3762 | 0.590 |
Why?
|
| Diet | 7 | 2026 | 536 | 0.590 |
Why?
|
| Colorectal Neoplasms | 6 | 2017 | 286 | 0.580 |
Why?
|
| Emergency Service, Hospital | 8 | 2021 | 1149 | 0.580 |
Why?
|
| Trauma Centers | 3 | 2015 | 130 | 0.580 |
Why?
|
| Incidence | 25 | 2026 | 1419 | 0.580 |
Why?
|
| Georgia | 11 | 2019 | 90 | 0.580 |
Why?
|
| Spirituality | 2 | 2019 | 43 | 0.570 |
Why?
|
| Attitude of Health Personnel | 5 | 2025 | 624 | 0.560 |
Why?
|
| Hyperlipidemias | 2 | 2016 | 34 | 0.560 |
Why?
|
| Bias | 3 | 2018 | 115 | 0.550 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 39 | 0.550 |
Why?
|
| Peer Review | 1 | 2018 | 26 | 0.540 |
Why?
|
| Education, Distance | 2 | 2009 | 35 | 0.530 |
Why?
|
| Marketing of Health Services | 2 | 2011 | 22 | 0.520 |
Why?
|
| Educational Status | 13 | 2020 | 277 | 0.510 |
Why?
|
| Obstetric Labor, Premature | 2 | 2009 | 31 | 0.510 |
Why?
|
| Communication | 4 | 2018 | 596 | 0.500 |
Why?
|
| Quality Assurance, Health Care | 7 | 2008 | 252 | 0.500 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 19 | 0.490 |
Why?
|
| Follow-Up Studies | 30 | 2018 | 2483 | 0.480 |
Why?
|
| Racism | 4 | 2022 | 92 | 0.470 |
Why?
|
| Medicaid | 5 | 2023 | 372 | 0.460 |
Why?
|
| Depressive Disorder | 5 | 2019 | 284 | 0.460 |
Why?
|
| Retrospective Studies | 27 | 2026 | 6872 | 0.460 |
Why?
|
| United States Department of Veterans Affairs | 8 | 2011 | 542 | 0.460 |
Why?
|
| Ambulatory Care | 3 | 2015 | 317 | 0.450 |
Why?
|
| Substance-Related Disorders | 5 | 2021 | 755 | 0.450 |
Why?
|
| Education, Medical, Continuing | 4 | 2011 | 92 | 0.450 |
Why?
|
| Survivors | 6 | 2019 | 186 | 0.450 |
Why?
|
| Stress, Psychological | 8 | 2025 | 474 | 0.450 |
Why?
|
| Rehabilitation Centers | 1 | 2015 | 11 | 0.440 |
Why?
|
| Poverty Areas | 3 | 2014 | 15 | 0.440 |
Why?
|
| Hospitals, University | 1 | 2015 | 55 | 0.430 |
Why?
|
| Tracheostomy | 1 | 2015 | 36 | 0.430 |
Why?
|
| Prevalence | 22 | 2024 | 1445 | 0.430 |
Why?
|
| Comorbidity | 17 | 2020 | 1119 | 0.430 |
Why?
|
| Biomarkers | 8 | 2024 | 1480 | 0.420 |
Why?
|
| Skilled Nursing Facilities | 1 | 2015 | 80 | 0.410 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 2010 | 152 | 0.400 |
Why?
|
| Patient Compliance | 8 | 2008 | 367 | 0.400 |
Why?
|
| Diabetes Mellitus | 8 | 2015 | 555 | 0.400 |
Why?
|
| Heart Diseases | 4 | 2013 | 223 | 0.400 |
Why?
|
| Critical Care | 4 | 2018 | 402 | 0.400 |
Why?
|
| Food Supply | 6 | 2021 | 55 | 0.390 |
Why?
|
| Disability Evaluation | 1 | 2014 | 216 | 0.390 |
Why?
|
| Registries | 11 | 2019 | 924 | 0.390 |
Why?
|
| Social Environment | 5 | 2017 | 93 | 0.380 |
Why?
|
| Coronary Artery Bypass | 8 | 2004 | 292 | 0.380 |
Why?
|
| Ambulatory Care Facilities | 2 | 2011 | 104 | 0.380 |
Why?
|
| Hospital Administration | 1 | 2013 | 43 | 0.370 |
Why?
|
| Length of Stay | 3 | 2015 | 828 | 0.370 |
Why?
|
| Chest Pain | 4 | 2021 | 85 | 0.370 |
Why?
|
| Chronic Disease | 5 | 2011 | 742 | 0.360 |
Why?
|
| Mammography | 5 | 1999 | 290 | 0.360 |
Why?
|
| Thrombolytic Therapy | 5 | 2005 | 195 | 0.360 |
Why?
|
| Drug Industry | 2 | 2010 | 41 | 0.360 |
Why?
|
| Cause of Death | 5 | 2020 | 221 | 0.350 |
Why?
|
| Breast Neoplasms | 5 | 2013 | 1222 | 0.350 |
Why?
|
| Continuity of Patient Care | 6 | 2014 | 174 | 0.340 |
Why?
|
| Insurance Coverage | 4 | 2006 | 98 | 0.340 |
Why?
|
| Appointments and Schedules | 3 | 1999 | 60 | 0.330 |
Why?
|
| Consumer Behavior | 2 | 2009 | 38 | 0.330 |
Why?
|
| Lung Neoplasms | 3 | 2013 | 702 | 0.330 |
Why?
|
| Physicians | 5 | 2010 | 474 | 0.330 |
Why?
|
| Physicians, Family | 2 | 2009 | 76 | 0.320 |
Why?
|
| Editorial Policies | 1 | 2011 | 54 | 0.320 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 460 | 0.320 |
Why?
|
| Aftercare | 4 | 2021 | 76 | 0.310 |
Why?
|
| Pulmonary Embolism | 3 | 2026 | 196 | 0.310 |
Why?
|
| Economic Recession | 2 | 2020 | 5 | 0.310 |
Why?
|
| C-Reactive Protein | 7 | 2019 | 170 | 0.300 |
Why?
|
| Drug Utilization | 4 | 2017 | 204 | 0.300 |
Why?
|
| Delivery of Health Care | 4 | 2017 | 431 | 0.300 |
Why?
|
| Self Efficacy | 2 | 2025 | 205 | 0.300 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 3 | 2018 | 33 | 0.300 |
Why?
|
| Treatment Outcome | 17 | 2018 | 5792 | 0.290 |
Why?
|
| Physician-Patient Relations | 7 | 2018 | 425 | 0.290 |
Why?
|
| Medical Assistance | 1 | 2009 | 10 | 0.290 |
Why?
|
| Attitude to Health | 3 | 2018 | 296 | 0.290 |
Why?
|
| Cardiovascular System | 3 | 2019 | 41 | 0.290 |
Why?
|
| Demography | 7 | 2018 | 178 | 0.290 |
Why?
|
| Environment | 3 | 2020 | 125 | 0.280 |
Why?
|
| Drug Costs | 1 | 2009 | 55 | 0.280 |
Why?
|
| Calcinosis | 5 | 2010 | 84 | 0.280 |
Why?
|
| Aging | 3 | 2024 | 771 | 0.280 |
Why?
|
| Managed Care Programs | 5 | 2017 | 86 | 0.270 |
Why?
|
| Physicians, Primary Care | 1 | 2009 | 78 | 0.270 |
Why?
|
| Health Personnel | 3 | 2018 | 384 | 0.270 |
Why?
|
| Prognosis | 14 | 2022 | 1784 | 0.270 |
Why?
|
| Cardiology | 5 | 2017 | 170 | 0.270 |
Why?
|
| Cholesterol | 5 | 2021 | 261 | 0.270 |
Why?
|
| ST Elevation Myocardial Infarction | 3 | 2018 | 95 | 0.270 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 120 | 0.270 |
Why?
|
| Pregnancy Outcome | 1 | 2009 | 197 | 0.260 |
Why?
|
| Self Care | 2 | 2018 | 215 | 0.260 |
Why?
|
| Chi-Square Distribution | 8 | 2017 | 413 | 0.260 |
Why?
|
| Medication Adherence | 4 | 2022 | 199 | 0.260 |
Why?
|
| Antihypertensive Agents | 3 | 2022 | 179 | 0.260 |
Why?
|
| Insurance Claim Review | 2 | 2015 | 75 | 0.260 |
Why?
|
| Patient Satisfaction | 4 | 2010 | 439 | 0.260 |
Why?
|
| Models, Statistical | 7 | 2010 | 309 | 0.260 |
Why?
|
| Health Care Reform | 3 | 2014 | 86 | 0.250 |
Why?
|
| Confidence Intervals | 8 | 2010 | 236 | 0.250 |
Why?
|
| Tachycardia, Ventricular | 3 | 2018 | 131 | 0.250 |
Why?
|
| Education, Continuing | 1 | 2007 | 24 | 0.250 |
Why?
|
| Vulnerable Populations | 2 | 2017 | 94 | 0.250 |
Why?
|
| Medical Audit | 3 | 2004 | 67 | 0.250 |
Why?
|
| Anxiety Disorders | 2 | 2018 | 200 | 0.250 |
Why?
|
| Data Collection | 8 | 2013 | 382 | 0.250 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2018 | 767 | 0.250 |
Why?
|
| Bioterrorism | 2 | 2007 | 8 | 0.240 |
Why?
|
| Severity of Illness Index | 10 | 2017 | 1559 | 0.240 |
Why?
|
| Fee-for-Service Plans | 4 | 2017 | 71 | 0.240 |
Why?
|
| Research Design | 6 | 2025 | 588 | 0.240 |
Why?
|
| Cardiovascular Agents | 3 | 2017 | 106 | 0.240 |
Why?
|
| Physical Examination | 2 | 2001 | 109 | 0.240 |
Why?
|
| Private Sector | 1 | 2005 | 12 | 0.230 |
Why?
|
| Anticoagulants | 5 | 2023 | 525 | 0.230 |
Why?
|
| Public Sector | 1 | 2005 | 13 | 0.230 |
Why?
|
| Urban Health | 5 | 2015 | 40 | 0.230 |
Why?
|
| Health Plan Implementation | 1 | 2006 | 40 | 0.230 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2006 | 55 | 0.230 |
Why?
|
| Outpatient Clinics, Hospital | 3 | 2011 | 39 | 0.230 |
Why?
|
| Unemployment | 3 | 2020 | 19 | 0.230 |
Why?
|
| Kidney Diseases | 4 | 2011 | 177 | 0.230 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2017 | 22 | 0.230 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 50 | 0.230 |
Why?
|
| Patient Education as Topic | 3 | 2018 | 481 | 0.230 |
Why?
|
| Emergency Treatment | 1 | 2005 | 55 | 0.220 |
Why?
|
| Glucose Intolerance | 1 | 2006 | 90 | 0.220 |
Why?
|
| Fast Foods | 3 | 2016 | 13 | 0.220 |
Why?
|
| Peer Review, Health Care | 2 | 2003 | 16 | 0.220 |
Why?
|
| Urban Population | 6 | 2020 | 200 | 0.220 |
Why?
|
| Affective Symptoms | 2 | 2009 | 17 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 5 | 2011 | 734 | 0.220 |
Why?
|
| Medically Uninsured | 4 | 2014 | 46 | 0.220 |
Why?
|
| Child Abuse | 3 | 2024 | 89 | 0.220 |
Why?
|
| Directive Counseling | 1 | 2005 | 39 | 0.220 |
Why?
|
| Motor Activity | 3 | 2013 | 345 | 0.220 |
Why?
|
| Computed Tomography Angiography | 1 | 2026 | 140 | 0.220 |
Why?
|
| Waist Circumference | 3 | 2021 | 47 | 0.210 |
Why?
|
| Infant, Low Birth Weight | 1 | 2004 | 59 | 0.210 |
Why?
|
| Biomedical Research | 2 | 2017 | 262 | 0.210 |
Why?
|
| Survival Rate | 9 | 2018 | 844 | 0.210 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2025 | 50 | 0.210 |
Why?
|
| Family Practice | 2 | 2003 | 215 | 0.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2024 | 47 | 0.210 |
Why?
|
| Leadership | 2 | 2023 | 211 | 0.210 |
Why?
|
| Mortality | 4 | 2019 | 161 | 0.210 |
Why?
|
| Specialties, Surgical | 2 | 2015 | 46 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2010 | 805 | 0.200 |
Why?
|
| Inflammation | 5 | 2015 | 1192 | 0.200 |
Why?
|
| Cardiology Service, Hospital | 3 | 2004 | 17 | 0.200 |
Why?
|
| Triglycerides | 4 | 2024 | 248 | 0.200 |
Why?
|
| Troponin | 1 | 2003 | 39 | 0.200 |
Why?
|
| Linear Models | 8 | 2017 | 405 | 0.200 |
Why?
|
| Social Discrimination | 2 | 2014 | 13 | 0.200 |
Why?
|
| Algorithms | 5 | 2016 | 1050 | 0.200 |
Why?
|
| Sex Distribution | 8 | 2017 | 252 | 0.200 |
Why?
|
| Patient Transfer | 2 | 2018 | 93 | 0.200 |
Why?
|
| Neoplasms | 5 | 2020 | 1368 | 0.200 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 1113 | 0.200 |
Why?
|
| Frail Elderly | 2 | 2022 | 114 | 0.200 |
Why?
|
| Financing, Personal | 3 | 2011 | 23 | 0.200 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2023 | 41 | 0.200 |
Why?
|
| Drug Prescriptions | 5 | 2010 | 164 | 0.200 |
Why?
|
| Prediabetic State | 1 | 2024 | 54 | 0.190 |
Why?
|
| Overweight | 2 | 2017 | 257 | 0.190 |
Why?
|
| Community Health Services | 2 | 2012 | 127 | 0.190 |
Why?
|
| Health Care Surveys | 8 | 2018 | 288 | 0.190 |
Why?
|
| Venous Thromboembolism | 2 | 2015 | 150 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2009 | 202 | 0.190 |
Why?
|
| Emergencies | 2 | 2020 | 123 | 0.190 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 59 | 0.190 |
Why?
|
| Weight Gain | 3 | 2012 | 166 | 0.190 |
Why?
|
| Ventricular Function, Left | 3 | 2020 | 285 | 0.190 |
Why?
|
| Heart Failure | 8 | 2020 | 957 | 0.190 |
Why?
|
| Anthrax | 1 | 2002 | 6 | 0.180 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 161 | 0.180 |
Why?
|
| Risk Adjustment | 4 | 2013 | 94 | 0.180 |
Why?
|
| DNA Methylation | 1 | 2024 | 302 | 0.180 |
Why?
|
| Medical Laboratory Science | 1 | 2001 | 10 | 0.180 |
Why?
|
| Transportation of Patients | 2 | 2018 | 50 | 0.180 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 142 | 0.180 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2002 | 58 | 0.170 |
Why?
|
| Pregnancy | 5 | 2025 | 2372 | 0.170 |
Why?
|
| Hematologic Tests | 1 | 2001 | 16 | 0.170 |
Why?
|
| Blood Glucose | 5 | 2021 | 497 | 0.170 |
Why?
|
| Drug Monitoring | 2 | 2020 | 202 | 0.170 |
Why?
|
| Emotions | 1 | 2003 | 233 | 0.170 |
Why?
|
| Thoracic Neoplasms | 1 | 2021 | 14 | 0.170 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 62 | 0.170 |
Why?
|
| Tobacco Use Cessation | 2 | 2013 | 32 | 0.160 |
Why?
|
| Mental Health | 2 | 2018 | 361 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 4 | 2016 | 159 | 0.160 |
Why?
|
| Carcinoma in Situ | 1 | 2021 | 36 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 407 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 3 | 2017 | 317 | 0.160 |
Why?
|
| Patients | 2 | 2012 | 115 | 0.160 |
Why?
|
| Bibliometrics | 1 | 2020 | 35 | 0.160 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2000 | 151 | 0.160 |
Why?
|
| Coffee | 1 | 2020 | 18 | 0.160 |
Why?
|
| Mohs Surgery | 1 | 2021 | 54 | 0.160 |
Why?
|
| Puerto Rico | 3 | 2025 | 138 | 0.160 |
Why?
|
| Extremities | 1 | 2021 | 63 | 0.160 |
Why?
|
| Mortality, Premature | 1 | 2020 | 7 | 0.160 |
Why?
|
| Hospitals, Veterans | 5 | 2005 | 159 | 0.160 |
Why?
|
| Fatigue | 2 | 2012 | 113 | 0.160 |
Why?
|
| Reminder Systems | 2 | 2011 | 75 | 0.160 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2019 | 3 | 0.160 |
Why?
|
| Ventricular Function, Right | 1 | 2020 | 28 | 0.150 |
Why?
|
| Anxiety | 5 | 2024 | 426 | 0.150 |
Why?
|
| Program Development | 3 | 2018 | 208 | 0.150 |
Why?
|
| Life Change Events | 2 | 2011 | 66 | 0.150 |
Why?
|
| Prescription Drug Misuse | 1 | 2019 | 20 | 0.150 |
Why?
|
| Organizational Objectives | 2 | 2017 | 59 | 0.150 |
Why?
|
| Nutrition Surveys | 2 | 2017 | 149 | 0.150 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 493 | 0.150 |
Why?
|
| Health Surveys | 9 | 2016 | 316 | 0.150 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 50 | 0.150 |
Why?
|
| Religion and Medicine | 1 | 2019 | 20 | 0.150 |
Why?
|
| Career Choice | 2 | 2017 | 126 | 0.150 |
Why?
|
| Primary Health Care | 5 | 2007 | 721 | 0.150 |
Why?
|
| Patient Participation | 2 | 2019 | 234 | 0.150 |
Why?
|
| Musculoskeletal Diseases | 1 | 2020 | 105 | 0.150 |
Why?
|
| Smokers | 1 | 2020 | 117 | 0.150 |
Why?
|
| Social Support | 5 | 2021 | 391 | 0.150 |
Why?
|
| Internship and Residency | 4 | 2009 | 800 | 0.150 |
Why?
|
| Life Expectancy | 2 | 2016 | 33 | 0.150 |
Why?
|
| Smoking Prevention | 2 | 2015 | 163 | 0.150 |
Why?
|
| Utilization Review | 1 | 1999 | 32 | 0.140 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 56 | 0.140 |
Why?
|
| Health Care Rationing | 1 | 1999 | 21 | 0.140 |
Why?
|
| Population Surveillance | 4 | 2014 | 210 | 0.140 |
Why?
|
| Economics | 1 | 2018 | 8 | 0.140 |
Why?
|
| Age Distribution | 6 | 2017 | 262 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 3 | 2011 | 196 | 0.140 |
Why?
|
| Osteoarthritis | 1 | 2020 | 146 | 0.140 |
Why?
|
| Administration, Oral | 1 | 2019 | 371 | 0.140 |
Why?
|
| Vaccination | 1 | 2001 | 377 | 0.140 |
Why?
|
| Mobile Applications | 1 | 2020 | 140 | 0.140 |
Why?
|
| Medical Indigency | 2 | 1998 | 6 | 0.140 |
Why?
|
| Consumer Health Information | 1 | 2018 | 36 | 0.140 |
Why?
|
| Papanicolaou Test | 1 | 1998 | 46 | 0.140 |
Why?
|
| Vaginal Smears | 1 | 1998 | 59 | 0.140 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2017 | 12 | 0.140 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2003 | 140 | 0.130 |
Why?
|
| Obesity, Abdominal | 1 | 2017 | 10 | 0.130 |
Why?
|
| Cholesterol, HDL | 2 | 2016 | 71 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2018 | 104 | 0.130 |
Why?
|
| Fibrinolytic Agents | 3 | 2006 | 178 | 0.130 |
Why?
|
| Professional-Family Relations | 1 | 2018 | 91 | 0.130 |
Why?
|
| Financing, Organized | 1 | 2017 | 16 | 0.130 |
Why?
|
| Communication Barriers | 1 | 2018 | 70 | 0.130 |
Why?
|
| Ventricular Fibrillation | 1 | 2018 | 107 | 0.130 |
Why?
|
| Employment | 1 | 2019 | 132 | 0.130 |
Why?
|
| Forecasting | 3 | 2013 | 230 | 0.130 |
Why?
|
| Intra-Abdominal Fat | 1 | 2017 | 36 | 0.130 |
Why?
|
| Marijuana Use | 1 | 2017 | 22 | 0.130 |
Why?
|
| Heart Rate | 3 | 2016 | 331 | 0.130 |
Why?
|
| Social Segregation | 1 | 2017 | 10 | 0.130 |
Why?
|
| Deficiency Diseases | 1 | 2017 | 12 | 0.130 |
Why?
|
| Diet, Mediterranean | 1 | 2017 | 16 | 0.130 |
Why?
|
| Herpes Zoster | 1 | 2017 | 22 | 0.130 |
Why?
|
| Iodine | 1 | 2017 | 21 | 0.130 |
Why?
|
| Melanoma | 1 | 2021 | 333 | 0.130 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 229 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 162 | 0.130 |
Why?
|
| Radiology | 1 | 2021 | 263 | 0.130 |
Why?
|
| Creatinine | 4 | 2016 | 135 | 0.130 |
Why?
|
| Skin Pigmentation | 2 | 2007 | 33 | 0.120 |
Why?
|
| Alcoholism | 2 | 2010 | 327 | 0.120 |
Why?
|
| Reproducibility of Results | 7 | 2015 | 1698 | 0.120 |
Why?
|
| Patient Admission | 1 | 2018 | 198 | 0.120 |
Why?
|
| Self-Management | 1 | 2018 | 71 | 0.120 |
Why?
|
| Mentors | 1 | 2017 | 118 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 83 | 0.120 |
Why?
|
| Sleep Wake Disorders | 2 | 2015 | 77 | 0.120 |
Why?
|
| Venous Thrombosis | 2 | 2015 | 112 | 0.120 |
Why?
|
| Interdisciplinary Communication | 2 | 2017 | 106 | 0.120 |
Why?
|
| Medical Records | 3 | 2005 | 140 | 0.120 |
Why?
|
| Mentoring | 1 | 2017 | 63 | 0.120 |
Why?
|
| Patient Credit and Collection | 1 | 2016 | 4 | 0.120 |
Why?
|
| Hypolipidemic Agents | 1 | 2016 | 25 | 0.120 |
Why?
|
| Perception | 2 | 2015 | 181 | 0.120 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 159 | 0.120 |
Why?
|
| Survival Analysis | 9 | 2018 | 576 | 0.120 |
Why?
|
| Health Education | 1 | 2017 | 189 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2019 | 382 | 0.120 |
Why?
|
| Health Services Needs and Demand | 3 | 2009 | 219 | 0.120 |
Why?
|
| Accountable Care Organizations | 1 | 2017 | 74 | 0.120 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 104 | 0.120 |
Why?
|
| Inpatients | 2 | 2015 | 319 | 0.120 |
Why?
|
| Psychosocial Deprivation | 1 | 2015 | 8 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 464 | 0.120 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2019 | 225 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 408 | 0.120 |
Why?
|
| Psychotherapy, Rational-Emotive | 1 | 2015 | 3 | 0.120 |
Why?
|
| Hemorrhage | 4 | 2022 | 286 | 0.120 |
Why?
|
| Proportional Hazards Models | 7 | 2017 | 740 | 0.110 |
Why?
|
| Child | 7 | 2024 | 4607 | 0.110 |
Why?
|
| Marriage | 1 | 2015 | 23 | 0.110 |
Why?
|
| Mass Screening | 6 | 2007 | 698 | 0.110 |
Why?
|
| Psychometrics | 3 | 2014 | 392 | 0.110 |
Why?
|
| Adaptation, Psychological | 3 | 2019 | 279 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2017 | 226 | 0.110 |
Why?
|
| Program Evaluation | 5 | 2013 | 493 | 0.110 |
Why?
|
| Analysis of Variance | 6 | 2002 | 602 | 0.110 |
Why?
|
| Multiple Chronic Conditions | 1 | 2015 | 39 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 350 | 0.110 |
Why?
|
| Caregivers | 1 | 2018 | 294 | 0.110 |
Why?
|
| Statistics as Topic | 5 | 2017 | 147 | 0.110 |
Why?
|
| Chlamydia trachomatis | 2 | 2005 | 60 | 0.110 |
Why?
|
| Social Isolation | 1 | 2015 | 38 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 527 | 0.110 |
Why?
|
| Chlamydia Infections | 2 | 2005 | 79 | 0.110 |
Why?
|
| Specialization | 2 | 2013 | 82 | 0.110 |
Why?
|
| Clinical Competence | 3 | 2009 | 726 | 0.110 |
Why?
|
| Social Behavior | 1 | 2015 | 85 | 0.110 |
Why?
|
| Parents | 2 | 2015 | 410 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2009 | 1422 | 0.110 |
Why?
|
| Wounds, Penetrating | 1 | 2014 | 33 | 0.100 |
Why?
|
| Disease Management | 1 | 2015 | 235 | 0.100 |
Why?
|
| Food Services | 1 | 2013 | 25 | 0.100 |
Why?
|
| Drug Therapy | 1 | 1994 | 56 | 0.100 |
Why?
|
| Commerce | 1 | 2014 | 58 | 0.100 |
Why?
|
| Interviews as Topic | 2 | 2013 | 531 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 801 | 0.100 |
Why?
|
| General Practice, Dental | 1 | 2013 | 6 | 0.100 |
Why?
|
| Cancer Care Facilities | 1 | 2013 | 17 | 0.100 |
Why?
|
| Social Perception | 1 | 2013 | 44 | 0.100 |
Why?
|
| Evidence-Based Medicine | 4 | 2006 | 460 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2021 | 822 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2013 | 23 | 0.100 |
Why?
|
| Dental Health Services | 1 | 2012 | 14 | 0.090 |
Why?
|
| Decision Making | 4 | 2011 | 417 | 0.090 |
Why?
|
| Metabolic Syndrome | 2 | 2005 | 146 | 0.090 |
Why?
|
| Body Weight | 2 | 2014 | 376 | 0.090 |
Why?
|
| Cardiac Catheterization | 2 | 2006 | 293 | 0.090 |
Why?
|
| Community-Based Participatory Research | 1 | 2013 | 62 | 0.090 |
Why?
|
| Medical Oncology | 1 | 2013 | 69 | 0.090 |
Why?
|
| Behavior Therapy | 2 | 2011 | 169 | 0.090 |
Why?
|
| Risk | 5 | 2015 | 374 | 0.090 |
Why?
|
| Acute Disease | 3 | 2018 | 663 | 0.090 |
Why?
|
| Models, Biological | 2 | 2016 | 1192 | 0.090 |
Why?
|
| Dentistry | 2 | 2008 | 8 | 0.090 |
Why?
|
| Recurrence | 4 | 2015 | 657 | 0.090 |
Why?
|
| California | 3 | 2011 | 177 | 0.090 |
Why?
|
| Internal Medicine | 3 | 2009 | 154 | 0.090 |
Why?
|
| Mouth Neoplasms | 2 | 2010 | 41 | 0.090 |
Why?
|
| Restaurants | 1 | 2011 | 12 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2015 | 420 | 0.090 |
Why?
|
| Population Groups | 1 | 2011 | 14 | 0.090 |
Why?
|
| Health Status Indicators | 2 | 2010 | 94 | 0.080 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2003 | 171 | 0.080 |
Why?
|
| Longevity | 2 | 2024 | 117 | 0.080 |
Why?
|
| Videodisc Recording | 1 | 2011 | 8 | 0.080 |
Why?
|
| Vegetables | 1 | 2011 | 68 | 0.080 |
Why?
|
| Health Promotion | 3 | 2015 | 516 | 0.080 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2011 | 22 | 0.080 |
Why?
|
| Hospitals, Urban | 2 | 2008 | 44 | 0.080 |
Why?
|
| Curriculum | 4 | 2017 | 608 | 0.080 |
Why?
|
| Electrocardiography | 3 | 2012 | 554 | 0.080 |
Why?
|
| Fruit | 1 | 2011 | 101 | 0.080 |
Why?
|
| Teaching | 2 | 2009 | 165 | 0.080 |
Why?
|
| Uric Acid | 1 | 2010 | 47 | 0.080 |
Why?
|
| Self Report | 3 | 2020 | 390 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 2009 | 364 | 0.080 |
Why?
|
| Tunica Media | 1 | 2010 | 6 | 0.080 |
Why?
|
| Multimorbidity | 2 | 2021 | 50 | 0.080 |
Why?
|
| Tunica Intima | 1 | 2010 | 16 | 0.080 |
Why?
|
| Insulin | 2 | 2006 | 695 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 3 | 2001 | 195 | 0.080 |
Why?
|
| Carotid Artery, Common | 1 | 2010 | 30 | 0.080 |
Why?
|
| Atherosclerosis | 2 | 2015 | 163 | 0.080 |
Why?
|
| Thyrotropin | 1 | 1990 | 35 | 0.080 |
Why?
|
| Radiography | 2 | 2021 | 555 | 0.080 |
Why?
|
| Models, Organizational | 2 | 2018 | 91 | 0.080 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 84 | 0.080 |
Why?
|
| Erythrocyte Indices | 1 | 1990 | 4 | 0.080 |
Why?
|
| Physical Fitness | 2 | 2008 | 93 | 0.080 |
Why?
|
| Oral Hygiene | 1 | 2010 | 14 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2006 | 235 | 0.080 |
Why?
|
| Feedback | 2 | 2001 | 91 | 0.080 |
Why?
|
| Computer-Assisted Instruction | 2 | 2008 | 80 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 91 | 0.080 |
Why?
|
| Delphi Technique | 1 | 2010 | 112 | 0.080 |
Why?
|
| Geographic Information Systems | 3 | 2015 | 22 | 0.080 |
Why?
|
| Electronic Mail | 1 | 2010 | 46 | 0.080 |
Why?
|
| Waist-Hip Ratio | 2 | 2006 | 12 | 0.070 |
Why?
|
| Pharmacies | 1 | 2009 | 36 | 0.070 |
Why?
|
| Databases, Factual | 4 | 2015 | 883 | 0.070 |
Why?
|
| Dyslipidemias | 3 | 2015 | 39 | 0.070 |
Why?
|
| Body Image | 1 | 2009 | 32 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 1989 | 30 | 0.070 |
Why?
|
| Hernia, Ventral | 2 | 2005 | 27 | 0.070 |
Why?
|
| Education, Medical | 2 | 2009 | 182 | 0.070 |
Why?
|
| Professional-Patient Relations | 1 | 2009 | 127 | 0.070 |
Why?
|
| Hospitals, Rural | 1 | 2008 | 17 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 731 | 0.070 |
Why?
|
| Practice Patterns, Dentists' | 1 | 2008 | 8 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 178 | 0.070 |
Why?
|
| Occupational Health | 1 | 2010 | 193 | 0.070 |
Why?
|
| Counseling | 4 | 2016 | 375 | 0.070 |
Why?
|
| Probability | 4 | 2010 | 170 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2010 | 266 | 0.070 |
Why?
|
| Pharmacists | 1 | 2009 | 130 | 0.070 |
Why?
|
| Regression Analysis | 5 | 2014 | 497 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 184 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2025 | 1656 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 261 | 0.060 |
Why?
|
| Prenatal Care | 1 | 2009 | 169 | 0.060 |
Why?
|
| Hostility | 2 | 2005 | 17 | 0.060 |
Why?
|
| Faculty, Medical | 1 | 2009 | 200 | 0.060 |
Why?
|
| Protective Factors | 2 | 2017 | 33 | 0.060 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2007 | 21 | 0.060 |
Why?
|
| Southeastern United States | 3 | 2013 | 26 | 0.060 |
Why?
|
| Family | 2 | 2006 | 245 | 0.060 |
Why?
|
| Menthol | 1 | 2006 | 6 | 0.060 |
Why?
|
| Hospitals, Public | 2 | 1999 | 7 | 0.060 |
Why?
|
| Prisoners | 1 | 2009 | 179 | 0.060 |
Why?
|
| Quality Improvement | 2 | 2023 | 464 | 0.060 |
Why?
|
| Rural Population | 1 | 2009 | 223 | 0.060 |
Why?
|
| Pulmonary Ventilation | 1 | 2006 | 36 | 0.060 |
Why?
|
| Weight Loss | 1 | 2009 | 276 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1141 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2007 | 113 | 0.060 |
Why?
|
| Patient-Centered Care | 2 | 2020 | 256 | 0.060 |
Why?
|
| Narcotics | 1 | 2006 | 57 | 0.060 |
Why?
|
| Schools, Medical | 2 | 2009 | 150 | 0.060 |
Why?
|
| Observation | 1 | 2005 | 30 | 0.060 |
Why?
|
| Chicago | 3 | 2015 | 26 | 0.060 |
Why?
|
| Health Services for the Aged | 1 | 2006 | 46 | 0.060 |
Why?
|
| Self Disclosure | 1 | 2005 | 37 | 0.060 |
Why?
|
| Preventive Medicine | 1 | 2005 | 25 | 0.060 |
Why?
|
| Language | 2 | 2021 | 154 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 181 | 0.060 |
Why?
|
| Ethics Committees, Research | 1 | 2005 | 32 | 0.060 |
Why?
|
| Family Health | 1 | 2005 | 68 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2003 | 1163 | 0.060 |
Why?
|
| Hospitals, Community | 1 | 2005 | 71 | 0.060 |
Why?
|
| Alcoholic Intoxication | 1 | 2005 | 27 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2005 | 67 | 0.050 |
Why?
|
| Cocaine | 1 | 2005 | 101 | 0.050 |
Why?
|
| Heparin | 1 | 2006 | 118 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2006 | 212 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2005 | 124 | 0.050 |
Why?
|
| Emergency Medicine | 1 | 2007 | 192 | 0.050 |
Why?
|
| Birth Order | 1 | 2024 | 2 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 3 | 2011 | 120 | 0.050 |
Why?
|
| Nursing, Practical | 1 | 2004 | 3 | 0.050 |
Why?
|
| Hospitals, Teaching | 2 | 2004 | 105 | 0.050 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 66 | 0.050 |
Why?
|
| Competitive Behavior | 1 | 2003 | 7 | 0.050 |
Why?
|
| Research | 1 | 2005 | 194 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2000 | 19 | 0.050 |
Why?
|
| Mid-Atlantic Region | 1 | 2003 | 2 | 0.050 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2003 | 16 | 0.050 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2003 | 14 | 0.050 |
Why?
|
| Nutritional Sciences | 1 | 2003 | 32 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2020 | 129 | 0.050 |
Why?
|
| Thyroxine | 2 | 1996 | 55 | 0.050 |
Why?
|
| Women's Health | 3 | 2000 | 374 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 118 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2004 | 65 | 0.050 |
Why?
|
| Cost of Illness | 2 | 2015 | 169 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 415 | 0.050 |
Why?
|
| Aspirin | 3 | 2004 | 172 | 0.050 |
Why?
|
| Medicare Part A | 1 | 2003 | 7 | 0.050 |
Why?
|
| Risk-Taking | 2 | 2007 | 159 | 0.050 |
Why?
|
| Nursing Staff, Hospital | 1 | 2004 | 72 | 0.050 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2003 | 47 | 0.050 |
Why?
|
| Myocardial Reperfusion | 1 | 2002 | 23 | 0.050 |
Why?
|
| Posture | 1 | 2003 | 127 | 0.050 |
Why?
|
| New England | 1 | 2003 | 271 | 0.050 |
Why?
|
| Insurance Claim Reporting | 2 | 1999 | 17 | 0.050 |
Why?
|
| International Classification of Diseases | 1 | 2003 | 136 | 0.050 |
Why?
|
| Pain | 3 | 2012 | 399 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2003 | 180 | 0.050 |
Why?
|
| Echocardiography | 1 | 2006 | 510 | 0.050 |
Why?
|
| Contraceptives, Oral | 1 | 2002 | 23 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2015 | 324 | 0.050 |
Why?
|
| Postoperative Complications | 5 | 2001 | 1326 | 0.050 |
Why?
|
| Ofloxacin | 1 | 2002 | 8 | 0.040 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 2002 | 9 | 0.040 |
Why?
|
| Echocardiography, Doppler | 2 | 2020 | 133 | 0.040 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2002 | 34 | 0.040 |
Why?
|
| Referral and Consultation | 2 | 2003 | 443 | 0.040 |
Why?
|
| Doxycycline | 1 | 2002 | 47 | 0.040 |
Why?
|
| Fluoroquinolones | 1 | 2002 | 33 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2003 | 233 | 0.040 |
Why?
|
| Diabetic Foot | 1 | 2001 | 11 | 0.040 |
Why?
|
| Death | 1 | 2001 | 33 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2001 | 58 | 0.040 |
Why?
|
| Diabetes Complications | 2 | 1999 | 106 | 0.040 |
Why?
|
| Dental Research | 2 | 2013 | 10 | 0.040 |
Why?
|
| Vietnam | 2 | 2018 | 185 | 0.040 |
Why?
|
| Stroke Volume | 2 | 2020 | 342 | 0.040 |
Why?
|
| Glucose | 1 | 2024 | 476 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2002 | 102 | 0.040 |
Why?
|
| Health Care Costs | 2 | 2017 | 223 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2021 | 57 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2000 | 38 | 0.040 |
Why?
|
| Secondary Prevention | 2 | 2015 | 165 | 0.040 |
Why?
|
| SEER Program | 1 | 2021 | 75 | 0.040 |
Why?
|
| Blood Pressure Determination | 2 | 2017 | 39 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2001 | 127 | 0.040 |
Why?
|
| Tea | 1 | 2020 | 32 | 0.040 |
Why?
|
| Influenza Vaccines | 1 | 2001 | 97 | 0.040 |
Why?
|
| Food Preferences | 2 | 2015 | 52 | 0.040 |
Why?
|
| Lipids | 2 | 2018 | 328 | 0.040 |
Why?
|
| Homicide | 1 | 2020 | 31 | 0.040 |
Why?
|
| Hyperthyroidism | 2 | 1990 | 19 | 0.040 |
Why?
|
| Bayes Theorem | 2 | 2016 | 125 | 0.040 |
Why?
|
| Diuretics | 2 | 2016 | 58 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2002 | 142 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2020 | 179 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2019 | 54 | 0.040 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2012 | 142 | 0.040 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1999 | 6 | 0.040 |
Why?
|
| Uncompensated Care | 1 | 1999 | 5 | 0.040 |
Why?
|
| Disease Progression | 2 | 2018 | 1220 | 0.040 |
Why?
|
| Computer User Training | 1 | 1999 | 7 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 496 | 0.040 |
Why?
|
| MEDLINE | 1 | 1999 | 13 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 2 | 2014 | 101 | 0.040 |
Why?
|
| Health Planning Guidelines | 1 | 1999 | 31 | 0.040 |
Why?
|
| Health Priorities | 1 | 1999 | 29 | 0.040 |
Why?
|
| Opioid-Related Disorders | 1 | 2006 | 528 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2002 | 347 | 0.040 |
Why?
|
| Heart | 2 | 2001 | 297 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2019 | 96 | 0.040 |
Why?
|
| Ethanol | 1 | 2022 | 330 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 1999 | 60 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 293 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 373 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2018 | 101 | 0.030 |
Why?
|
| Health Maintenance Organizations | 1 | 1998 | 61 | 0.030 |
Why?
|
| Fibrinogen | 1 | 1998 | 33 | 0.030 |
Why?
|
| Platelet Activation | 1 | 1998 | 31 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2017 | 5 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2019 | 274 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2018 | 34 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2021 | 393 | 0.030 |
Why?
|
| Herpes Zoster Ophthalmicus | 1 | 2017 | 6 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 222 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 2017 | 24 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 703 | 0.030 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2017 | 10 | 0.030 |
Why?
|
| Stakeholder Participation | 1 | 2017 | 29 | 0.030 |
Why?
|
| Outpatients | 2 | 2006 | 143 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 321 | 0.030 |
Why?
|
| Research Personnel | 1 | 2017 | 82 | 0.030 |
Why?
|
| Professional Competence | 1 | 2017 | 91 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2016 | 24 | 0.030 |
Why?
|
| Insulin Resistance | 2 | 2015 | 414 | 0.030 |
Why?
|
| Reproductive History | 1 | 2016 | 17 | 0.030 |
Why?
|
| Marital Status | 1 | 2016 | 44 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 68 | 0.030 |
Why?
|
| Peroxidases | 1 | 1996 | 6 | 0.030 |
Why?
|
| Porphyrins | 1 | 1996 | 10 | 0.030 |
Why?
|
| Gastric Juice | 1 | 1996 | 9 | 0.030 |
Why?
|
| Software | 1 | 2000 | 400 | 0.030 |
Why?
|
| Tuberculin Test | 1 | 1996 | 9 | 0.030 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1996 | 19 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 1996 | 43 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 137 | 0.030 |
Why?
|
| Minnesota | 2 | 2011 | 45 | 0.030 |
Why?
|
| Veterans | 1 | 2004 | 761 | 0.030 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2015 | 13 | 0.030 |
Why?
|
| Statistics, Nonparametric | 3 | 2001 | 213 | 0.030 |
Why?
|
| Time | 1 | 2015 | 30 | 0.030 |
Why?
|
| Fathers | 1 | 1995 | 22 | 0.030 |
Why?
|
| Random Allocation | 1 | 1996 | 200 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 149 | 0.030 |
Why?
|
| Health Services | 1 | 2016 | 80 | 0.030 |
Why?
|
| Minority Groups | 1 | 1997 | 141 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2015 | 46 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 1996 | 93 | 0.030 |
Why?
|
| Telemedicine | 1 | 2020 | 362 | 0.030 |
Why?
|
| Bone Density | 2 | 2007 | 142 | 0.030 |
Why?
|
| Federal Government | 1 | 1994 | 18 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 52 | 0.030 |
Why?
|
| Iowa | 3 | 1999 | 21 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2005 | 117 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2018 | 750 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1994 | 106 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2016 | 175 | 0.030 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1993 | 8 | 0.030 |
Why?
|
| Deductibles and Coinsurance | 1 | 1993 | 9 | 0.030 |
Why?
|
| Texas | 1 | 1993 | 59 | 0.030 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 1993 | 3 | 0.020 |
Why?
|
| Occupations | 2 | 2005 | 52 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 871 | 0.020 |
Why?
|
| Interinstitutional Relations | 1 | 2013 | 36 | 0.020 |
Why?
|
| Reference Values | 2 | 2006 | 327 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1993 | 81 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 88 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1993 | 136 | 0.020 |
Why?
|
| Tuberculosis | 1 | 1996 | 309 | 0.020 |
Why?
|
| Behavior | 1 | 2012 | 36 | 0.020 |
Why?
|
| Epitopes | 1 | 1993 | 291 | 0.020 |
Why?
|
| Tobacco Products | 1 | 2012 | 63 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2014 | 263 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 169 | 0.020 |
Why?
|
| Sleep | 1 | 2015 | 240 | 0.020 |
Why?
|
| Exercise Test | 2 | 2008 | 257 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 291 | 0.020 |
Why?
|
| Albuminuria | 1 | 2011 | 28 | 0.020 |
Why?
|
| Prostatic Diseases | 1 | 1991 | 9 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1993 | 220 | 0.020 |
Why?
|
| Family Relations | 1 | 2011 | 23 | 0.020 |
Why?
|
| Public Policy | 1 | 2011 | 38 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2010 | 14 | 0.020 |
Why?
|
| Culture | 1 | 2011 | 82 | 0.020 |
Why?
|
| Prostatectomy | 1 | 1991 | 103 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1990 | 30 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 105 | 0.020 |
Why?
|
| Contraindications | 2 | 2002 | 52 | 0.020 |
Why?
|
| Professional Review Organizations | 2 | 2001 | 2 | 0.020 |
Why?
|
| Social Welfare | 1 | 2010 | 23 | 0.020 |
Why?
|
| Nonprescription Drugs | 1 | 2009 | 17 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 1993 | 524 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 296 | 0.020 |
Why?
|
| Arthritis | 1 | 2009 | 52 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2009 | 56 | 0.020 |
Why?
|
| Child of Impaired Parents | 1 | 2009 | 23 | 0.020 |
Why?
|
| Goiter | 1 | 1989 | 9 | 0.020 |
Why?
|
| Prescription Drugs | 1 | 2009 | 49 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1989 | 60 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2009 | 101 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1989 | 128 | 0.020 |
Why?
|
| Models, Educational | 1 | 2009 | 67 | 0.020 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2008 | 23 | 0.020 |
Why?
|
| Education, Dental, Continuing | 1 | 2008 | 4 | 0.020 |
Why?
|
| Postoperative Care | 2 | 2004 | 125 | 0.020 |
Why?
|
| Parenting | 1 | 2009 | 75 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 544 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2008 | 125 | 0.020 |
Why?
|
| Carrier State | 1 | 1987 | 20 | 0.020 |
Why?
|
| Cephalosporins | 1 | 1987 | 21 | 0.020 |
Why?
|
| Cities | 1 | 2008 | 33 | 0.020 |
Why?
|
| Prisons | 1 | 2009 | 120 | 0.020 |
Why?
|
| Wisconsin | 2 | 1998 | 17 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 730 | 0.020 |
Why?
|
| Connecticut | 2 | 1998 | 90 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2010 | 335 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2003 | 1015 | 0.020 |
Why?
|
| Awareness | 1 | 2007 | 73 | 0.020 |
Why?
|
| Rheumatic Diseases | 1 | 2007 | 42 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 69 | 0.020 |
Why?
|
| Diphosphonates | 1 | 2007 | 33 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2007 | 49 | 0.020 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2006 | 11 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 1987 | 130 | 0.020 |
Why?
|
| Marijuana Abuse | 1 | 2006 | 23 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2005 | 35 | 0.010 |
Why?
|
| Life Tables | 1 | 2005 | 23 | 0.010 |
Why?
|
| Peptic Ulcer | 1 | 2005 | 18 | 0.010 |
Why?
|
| Cocaine-Related Disorders | 1 | 2006 | 81 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2005 | 65 | 0.010 |
Why?
|
| Accreditation | 1 | 2006 | 76 | 0.010 |
Why?
|
| Population Density | 1 | 2005 | 13 | 0.010 |
Why?
|
| Adolescent Health Services | 1 | 2005 | 19 | 0.010 |
Why?
|
| Community Participation | 1 | 2005 | 48 | 0.010 |
Why?
|
| Training Support | 1 | 2005 | 20 | 0.010 |
Why?
|
| Women's Health Services | 1 | 2005 | 30 | 0.010 |
Why?
|
| Medicine | 1 | 2005 | 53 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2005 | 261 | 0.010 |
Why?
|
| Stereotyping | 1 | 2004 | 19 | 0.010 |
Why?
|
| Infant | 1 | 1989 | 1693 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 2003 | 13 | 0.010 |
Why?
|
| Critical Pathways | 1 | 2004 | 31 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 2003 | 29 | 0.010 |
Why?
|
| Taste | 1 | 2003 | 39 | 0.010 |
Why?
|
| Education, Nursing | 1 | 2004 | 41 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 174 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1989 | 2061 | 0.010 |
Why?
|
| Cultural Diversity | 1 | 2004 | 54 | 0.010 |
Why?
|
| Graft Survival | 1 | 2004 | 296 | 0.010 |
Why?
|
| Pediatrics | 1 | 2005 | 264 | 0.010 |
Why?
|
| Ambulances | 1 | 2002 | 24 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2004 | 302 | 0.010 |
Why?
|
| Organizational Affiliation | 1 | 2002 | 5 | 0.010 |
Why?
|
| New Hampshire | 1 | 2002 | 43 | 0.010 |
Why?
|
| Competency-Based Education | 1 | 2002 | 31 | 0.010 |
Why?
|
| Knowledge | 1 | 2002 | 32 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 2001 | 35 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2002 | 213 | 0.010 |
Why?
|
| ROC Curve | 1 | 2001 | 292 | 0.010 |
Why?
|
| Learning | 1 | 2002 | 186 | 0.010 |
Why?
|
| Morbidity | 1 | 2000 | 110 | 0.010 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 1999 | 4 | 0.010 |
Why?
|
| Ventilator Weaning | 1 | 1999 | 21 | 0.010 |
Why?
|
| Causality | 1 | 1999 | 60 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1999 | 40 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2000 | 251 | 0.010 |
Why?
|
| Documentation | 1 | 2000 | 134 | 0.010 |
Why?
|
| Subject Headings | 1 | 1999 | 2 | 0.010 |
Why?
|
| Postmenopause | 1 | 2000 | 238 | 0.010 |
Why?
|
| Clinical Medicine | 1 | 1999 | 16 | 0.010 |
Why?
|
| Fees and Charges | 1 | 1998 | 17 | 0.010 |
Why?
|
| Reoperation | 1 | 1999 | 302 | 0.010 |
Why?
|
| Louisiana | 1 | 1998 | 16 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 1998 | 48 | 0.010 |
Why?
|
| India | 1 | 1998 | 164 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 1997 | 6 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1996 | 16 | 0.010 |
Why?
|
| Benzidines | 1 | 1996 | 1 | 0.010 |
Why?
|
| Pepsin A | 1 | 1996 | 8 | 0.010 |
Why?
|
| Systole | 1 | 1996 | 109 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1996 | 52 | 0.010 |
Why?
|
| Diastole | 1 | 1996 | 90 | 0.010 |
Why?
|
| Reference Standards | 1 | 1996 | 76 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1996 | 83 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1996 | 117 | 0.010 |
Why?
|
| Workplace | 1 | 1997 | 177 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1996 | 136 | 0.010 |
Why?
|
| Refugees | 1 | 1996 | 75 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1996 | 464 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 753 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1993 | 35 | 0.010 |
Why?
|
| Colonic Polyps | 1 | 1993 | 25 | 0.010 |
Why?
|
| Cardiac Output, Low | 1 | 1993 | 12 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1993 | 83 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1991 | 42 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1991 | 130 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1991 | 199 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 875 | 0.000 |
Why?
|
| Nasal Cavity | 1 | 1987 | 9 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1987 | 180 | 0.000 |
Why?
|